Jing Fu

5PUBLICATIONS
18CO-AUTHORS
Gene and molecular therapyAutoimmunityHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 05, 2026
Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop.

|Jul 29, 2026
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis.

|Jul 17, 2023
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease.

Jing Fu, Shirong Li, Huihui Ma

|Feb 24, 2023
Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects.

Shirong Li, Jing Fu, Christopher J Walker

|Mar 03, 2018
IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation.

Shirong Li, Jing Fu, Hui Wang

Pageof 1

Frequent Collaborators

4 joint publications

Suzanne Lentzsch

1 joint publications

Shirong Li

1 joint publications

Rajshekhar Chakraborty

1 joint publications

Niha Mamillapalli